Here are 12 key market players:
1. Arthrex
2. Arteriocyte Medical Systems
3. DePuy Synthes
4. Biomet
5. Cesca Therapeutics
6. Dr. PRP America
7. EmCyte Corp.
8. AdiStem
9. Exactech
10. Nuo Therapeutics
11. Regen Lab
12. Harvest Technologies Corp.
More articles on biologics:
RTI Surgical & Aziyo Biologics ink deal: 4 things to know
Asterias Biotherapeutics’ stem cell-derived treatment for spinal cord injury holds promise: 4 things to know
Ortho RTi receives extension on 2.1M+ warrants: 3 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
